PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 108 filers reported holding PULMONX CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,502,658 | -10.1% | 726,298 | +14.1% | 1.42% | +28.4% |
| Q2 2023 | $8,343,309 | +17.1% | 636,408 | -0.2% | 1.10% | +53.3% |
| Q1 2023 | $7,127,395 | -16.8% | 637,513 | -37.3% | 0.72% | +63.1% |
| Q4 2022 | $8,567,055 | -34.0% | 1,016,258 | +30.5% | 0.44% | -41.1% |
| Q3 2022 | $12,978,000 | -33.6% | 778,978 | -41.3% | 0.75% | -33.8% |
| Q2 2022 | $19,534,000 | +33.5% | 1,327,065 | +125.0% | 1.13% | +139.2% |
| Q1 2022 | $14,631,000 | -5.0% | 589,722 | +22.8% | 0.47% | -15.1% |
| Q4 2021 | $15,396,000 | -49.2% | 480,088 | -43.0% | 0.56% | -39.5% |
| Q3 2021 | $30,287,000 | +15.3% | 841,764 | +41.4% | 0.92% | +12.9% |
| Q2 2021 | $26,262,000 | +29.6% | 595,231 | +34.4% | 0.82% | +41.6% |
| Q1 2021 | $20,258,000 | -25.2% | 442,896 | +12.8% | 0.58% | -41.4% |
| Q4 2020 | $27,100,000 | – | 392,642 | – | 0.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $1,494,000 | 12.13% |
| Miura Global Management | 595,000 | $14,762,000 | 4.80% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,695,341 | $91,681,000 | 2.05% |
| Millrace Asset Group, Inc. | 78,859 | $1,956,000 | 1.42% |
| NEXT CENTURY GROWTH INVESTORS LLC | 436,034 | $10,818,000 | 1.08% |
| Novo Holdings A/S | 410,155 | $10,176,000 | 0.54% |
| PURA VIDA INVESTMENTS, LLC | 589,722 | $14,631,000 | 0.47% |
| Rock Springs Capital Management LP | 702,400 | $17,427,000 | 0.44% |
| RTW INVESTMENTS, LP | 798,255 | $19,805,000 | 0.41% |
| Regis Management CO LLC | 82,070 | $2,036,000 | 0.36% |